Gofintech Innov (00290) announced that the company will hold a special shareholder meeting on the morning of October 4, 2024, in order to...
According to the announcement from Gofintech Innov (00290), the company has scheduled a special shareholder meeting on the morning of October 4, 2024, to consider and deliberate on the ordinary resolution regarding the acquisition of 26.15% equity of Wealthink AI (01140) through the issuance of shares at the price (with or without revision).
At the special shareholder meeting, the following motions will be proposed and approved by the shareholders:
(a) Approval, confirmation, and ratification of the sale and purchase agreement, with copies marked with the letter "A" provided to the special shareholder meeting and signed by the chairman of the special shareholder meeting for identification purposes) and the proposed transaction thereunder;
(b) Subject to approval by the Hong Kong Stock Exchange Listing Committee for the listing of the consideration shares and upon the completion of the transaction, approval of the granting of a special authorization to the directors of the company to issue and allot the consideration shares to the seller (or as instructed by the seller) in accordance with the terms and conditions of the sale and purchase agreement, provided that such special authorization shall be supplemental and not prejudice or rescind any general or special authorization granted or may from time to time be granted to the directors by the shareholders of the company prior to the passing of this ordinary resolution; and
(c) Authorizing the directors, in their absolute discretion, to take any actions and matters, sign and execute (with or without affixing the company's seal) any relevant documents, agreements, or deeds, and to take any steps and actions which the directors consider necessary, appropriate, suitable or expedient in connection with the effectiveness of the sale and purchase agreement and the proposed transaction thereunder, and agreeing with such changes, amendments, or waivers as the directors consider to be in the overall interests of the company and its shareholders.